Latest news with #NextFrontier
Business Wire
a day ago
- Business
- Business Wire
JCR Pharmaceuticals Announces Launch of Mucopolysaccharidosis (MPS) Type II Disease Awareness Film Featured in
HYOGO, Japan--(BUSINESS WIRE)-- JCR Pharmaceuticals Co., Ltd. (TSE 4552; 'JCR'), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced the launch of a film featured in The Next Frontier, a global branded film series presented by the Biotechnology Innovation Organization (BIO) and produced by BBC StoryWorks Commercial Productions. The Next Frontier series explores how biotechnology can be used effectively to address urgent challenges the world faces. As part of the series, the JCR-sponsored film tells the story of a family affected by mucopolysaccharidosis type II (MPS II, or Hunter syndrome), a rare, progressive, life-threatening lysosomal storage disorder. 'This film demonstrates the hardships and challenges that people living with MPS II face on a daily basis from the perspective of a family affected by this devastating and life-limiting disease,' said Shin Ashida, Chairman, President and CEO of JCR Pharmaceuticals. 'We are honored to participate in this important video series to shine a spotlight on MPS II and increase awareness worldwide about this debilitating rare disease for which patients desperately need new treatment options. This impactful story is a great illustration of how collaborating with patient communities drives progress. We are committed to supporting the MPS II patient community, and we look forward to advancing our investigational therapy for people living with MPS II.' The Next Frontier series highlights biotechnology's potential to help create a healthier and more sustainable future for all. The series delves into how powerful storytelling can turn complexity into clarity and breakthrough science into emotional connection. The series debuted at the BIO International Convention, taking place from June 16-19, 2025. Watch the JCR film here, and view the full The Next Frontier series here. About The Next Frontier Series The Next Frontier is a global branded film series presented by Biotechnology Innovation Organization (BIO) and produced by BBC StoryWorks Commercial Productions, and it explores how biotechnology can be used effectively to address urgent challenges the world faces. The series highlights biotechnology's potential to help create a healthier and more sustainable future for all. The series delves into how powerful storytelling can turn complexity into clarity and breakthrough science into emotional connection and features the tools that help the public not just understand biotech but believe in its potential. If the future depends on science, it also depends on the stories we tell. About Biotechnology Innovation Organization (BIO) BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services, worldwide. BIO members are at the forefront of researching and developing innovative biotechnologies across healthcare, agriculture, industry, and the environment. Corporate members range from entrepreneurial companies developing a first product to Fortune 500 multinationals. BIO is helping to drive a revolution that aims to cure patients, protect our climate, and nourish humanity. About Mucopolysaccharidosis Type II (Hunter Syndrome) Mucopolysaccharidosis type II (MPS II, or Hunter syndrome) is an X-linked recessive lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase, an enzyme that breaks down complex carbohydrates called glycosaminoglycans (GAGs, also known as mucopolysaccharides) in the body. Hunter syndrome, which affects an estimated 2,000-3,000 individuals worldwide (according to JCR research), gives rise to a wide range of somatic and neurological symptoms. The current standard of care for Hunter syndrome is enzyme replacement therapy. Central nervous system symptoms related to MPS II have been unmet medical needs so far. About JCR Pharmaceuticals Co., Ltd. JCR Pharmaceuticals Co., Ltd. (TSE 4552) is a global specialty pharmaceutical company that develops treatments that go beyond rare diseases to solve the world's most complex healthcare challenges. We continue to build upon our 50-year legacy in Japan while expanding our global footprint into the U.S., Europe, and Latin America. We improve patients' lives by applying our scientific expertise and unique technologies to research, develop, and deliver next-generation therapies. Our approved products in Japan include therapies for the treatment of growth disorder, MPS II (Hunter syndrome), Fabry disease, acute graft-versus host disease, and renal anemia. Our investigational products in development worldwide are aimed at treating rare diseases including MPS I (Hurler, Hurler-Scheie and Scheie syndrome), MPS II, MPS IIIA and B (Sanfilippo syndrome type A and B), and more. Our core values – Putting people first, Forging our own path, Always advancing, and Committed to excellence – mean that the work we do benefits all our stakeholders, including employees, partners, and patients. We strive to expand the possibilities for patients while accelerating medical advancement at a global level. For more information, please visit the global website:
Associated Press
16-04-2025
- Business
- Associated Press
TeckNexus Unveils 'AI Pulse: Telecom's Next Frontier' Magazine – MWC 2025 Special Edition
Explore how 30+ CxOs and 7 insight reports define AI's expanding role across telecom, enterprise platforms, and connected industries. 'AI Pulse: Telecom's Next Frontier is not just about innovation—it's about how AI is becoming the foundational layer of tomorrow's networks and platforms'— Hema Kadia, Founder and CEO TeckNexus SAN FRANCISCO, CA, UNITED STATES, April 16, 2025 / / -- TeckNexus, a technology research and content platform focused on AI, private networks, 5G, and emerging connectivity trends, has released its latest industry edition: AI Pulse: Telecom's Next Frontier. Released post MWC 2025, this 130+ page digital magazine explores how artificial intelligence (AI) is transforming the telecom ecosystem — strategically, structurally, and commercially. The edition features insights from more than 30 global telecom CxOs, including leaders from Telefónica, Vodafone, Telstra, Airtel, Telenor, and China Mobile. These executives share how AI is being embedded across networks, enterprise platforms, and digital services. The content reflects a telecom sector in transition, one where AI is becoming the core architecture driving innovation, efficiency, and growth. Released after one of the industry's most important annual events, this edition captures the most current thinking, real-world case studies, and collaborative strategies presented at MWC 2025. It provides decision-makers with timely insights into what's shaping telecom transformation, from AI infrastructure to multi-industry integration. Topics explored in the magazine include AI Ops, edge computing, large language models (LLMs), AI-as-a-Service, and governance models. Readers will also gain insight into the role of AI across connected industries such as manufacturing, transportation, fintech, entertainment, and satellite communications. The digital magazine is available to access online via the TeckNexus website and provides strategic and actionable insights for telecom leaders, enterprise decision-makers, analysts, and innovators working at the intersection of AI and connectivity. In addition to the magazine, TeckNexus has published a curated set of post-MWC 2025 insight reports. These research-driven publications provide deeper analysis of trends, innovations, and CxO strategies shaping the future of telecom and adjacent industries. The reports are available individually or as a bundled collection for organizations seeking a comprehensive understanding of the landscape. The seven insight reports cover a range of high-impact topics. These include: 1. AI in Telecom – covering infrastructure, deployment strategies, and the evolution toward AI-native networks. 2. Connected Industries: Smart Manufacturing and Production – detailing how private 5G and AI are transforming factories and industrial workflows. 3. Connected Industries: Smart Mobility and Transport – analyzing intelligent mobility solutions, autonomous systems, and logistics. 4. Connected Industries: FinTech and Digital Finance – exploring embedded payments, secure mobile infrastructure, and the next $2 trillion FinTech wave. 5. Connected Industries: Sports, Media, and Entertainment – focusing on real-time fan engagement, AI-powered content, and monetization through super apps. 6. Satellite Connectivity and NTN – providing insights into Direct-to-Device (D2D), rural coverage, and satellite-mobile convergence. 7. Executive Insights – featuring exclusive commentary from 48 CxOs on innovation, governance, and cross-industry collaboration. TeckNexus emphasizes the importance of leadership alignment and strategic collaboration in an AI-driven future. The CxO contributions in this edition provide readers with not just technology updates but also executive-level reflections on culture change, national innovation agendas, platform thinking, and policy reform. These insights offer a unique perspective into how telcos are repositioning themselves for long-term competitiveness and value creation. 'This special edition captures the strategic momentum behind AI in telecom,' said Hema Kadia, Founder and CEO of TeckNexus. 'It is both a reflection of industry progress and a guide to what's next—from operational transformation to cross-industry impact.' The magazine also includes a series of in-depth features aligned with key themes discussed at MWC 2025. These include: 1. The evolution from telco to techco. 2. Global telecom policy and AI governance. 3. AI's role in sustainability and climate innovation. 4. Satellite-mobile convergence and rural connectivity. 5. The future of fan engagement and immersive media. 6. Ethical AI, digital sovereignty, and geopolitical impacts. The full edition of AI Pulse: Telecom's Next Frontier is now available to access at: Beyond digital magazines, TeckNexus provides research publications, executive interviews, curated insight reports, and multimedia content that help stakeholders stay ahead in the telecom and enterprise tech landscape. With a focus on actionable insights, industry storytelling, and innovation strategy, TeckNexus serves as a trusted platform for CxOs, product leaders, and ecosystem partners worldwide. TeckNexus is also preparing its upcoming edition, AI for Telcos & Enterprises. Organizations interested in contributing through sponsored content, executive interviews, or case studies are invited to connect with the editorial team. Hema Kadia TeckNexus email us here Visit us on social media: LinkedIn YouTube Other Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
